67-Year-Old Male Patient With Acute Myeloid Leukaemia With Myelodysplasia-Related Changes (AML-MRC) and a Complex Karyotype

Dr Satarupa Choudhuri presents a case study of a high-risk* AML patient who was treated during the COVID pandemic.

Prescribing information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: AML Landscape Safety Vyxeos Liposomal Data


Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com

UK-VYX-2100014 | March 2021